Skip to Main Content
(Press Enter)
Ochsner Health Network – 2019 Annual Report

2019 Performance
Ochsner Health Network Performance

OHN’s internal performance measurements in 2019 were exceptional — recording increases over prior year in each of the high-priority chronic disease initiatives. 2019 was OHN’s second year of using the payor-agnostic measurement tool we developed in 2018 to track our performance on over 40 measures, using both industry standard measure specifications and internally created algorithms to integrate clinical and claims data from a variety of provider and payor data sources.

Quality Blue Primary Care (QBPC) Performance Measures

Launched in 2014, QBPC is a Blue Cross and Blue Shield of LA population health and quality improvement program designed to improve the overall health of the population.

  • Diabetes Mellitus - Patients with a diagnosis of type 1 or type 2 diabetes mellitus on one or more medications, either oral agent(s), insulin(s), or other anti-hyperglycemia medications are eligible for QBPC enrollment. Prediabetes, metabolic syndrome or other pre-diabetic syndromes are not eligible for QBPC enrollment. Patients who are co-managed with an endocrinologist may be enrolled in QBPC.
  • Vascular Disease - Enrollment for QBPC includes any of the established diagnoses for Ischemic Vascular Disease using ICD-9 codes. Due to the extensive variety of testing that may be performed, enrollment is based on diagnostic codes; however, these diagnoses should be supported by radiologic, angiographic or functional cardiac testing that indicated arteriosclerotic pathology.
  • Vascular Pharmacy Measure - This clinical quality measure includes Statin use + Proportion of Days Covered >.80
  • Hypertension - Patients with a history of hypertension on one or more medications for hypertension are considered “hypertensive” for QBPC purposes regardless of blood pressure reading(s).
  • Chronic Kidney Disease – Patients with a decline in kidney function for three or more months - as determined by an estimate of the Glomerular Filtration Rate (eGFR) of less than 60 mL/min/1.73 m2 OR significant albuminuria NOT on any form of renal replacement therapy including kidney transplant - are eligible for QBPC enrollment.

Optimal Diabetes Care

40%
2018
45%
2019

Optimal Vascular Care

48%
2018
56%
2019

Optimal Vascular
Pharmacy

63%
2018
72%
2019

Optimal Chronic Kidney Disease Care

78%
2018
82%
2019

Optimal Hypertension Care

76%
2018
79%
2019

Financials 2018-2019 – Savings & Incentives

OACN Celebrates MSSP Shared Savings

BCBS-QBPC

Paid Amount

Bar chart showing the BCBS-QBPC yearly paid amount from 2017 through 2019

OHN Blue Advantage Quality

Paid Amount

Bar chart showing the OHN Blue Advantage Quality yearly paid amount from 2017 through 2019

United ACO

Savings Generated

Bar chart showing the United ACO yearly savings generated from 2017 through 2019

Paid Amount

Bar chart showing the United ACO yearly paid amount from 2017 through 2019

Ochsner Accountable Care Network

Savings Generated

Bar chart showing the Ochsner Accountable Care Network yearly savings generated from 2017 through 2019

Paid Amount

Bar chart showing the Ochsner Accountable Care Network yearly paid amount from 2017 through 2019

BCBS-QBPC: Paid Amount

OHN Blue Advantage Quality: Paid Amount

United ACO: Savings Generated

United ACO: Paid Amount

Ochsner Accountable Care Network: Savings Generated

Ochsner Accountable Care Network: Paid Amount